Aegerion To Pay $35M To Settle Criminal, False Claims Cases, $4M To Settle SEC Action
BOSTON — Aegerion Pharmaceuticals Inc. will pay more than $35 million to resolve federal criminal misdemeanor charges and civil claims that it promoted its expensive cholesterol drug Juxtapid for off-label uses...To view the full article, register now.
Already a subscriber? Click here to view full article